Safety and Efficacy of Intravenous IDOV-SAFETM in Patients With Advanced Solid Tumors

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Neoplasms

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, China
Contact: Study coordinator (Ning Li, MD) · lining@cicams.ac.cn · 15601395554

Study leads

Ning Li, MD
Principal Investigator
Cancer Institute and Hospital, Chinese Academy of Medical Sciences

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)

Carcinoma · Renal Cell Carcinoma · RCC

Abroad (travel likely)Recruiting

Nanjing, China

Utidelone Versus Docetaxel in HER2-negative Locally Advanced or Metastatic Breast Cancer

Breast Neoplasms · Locally Advanced or Metastatic Breast Cancer

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China · Hunan, China